Literature DB >> 18174461

VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.

Masato Murakami1, Yujuan Zheng, Masanori Hirashima, Toshio Suda, Yohei Morita, Jun Ooehara, Hideo Ema, Guo-Hua Fong, Masabumi Shibuya.   

Abstract

OBJECTIVE: Angiogenesis and lymphangiogenesis are complex phenomena that involve the interplay of several growth factors and receptors. Recently, we have demonstrated that in Keratin-14 (K14) promoter-driven Vegf-A transgenic (Tg) mice, not only angiogenesis but also lymphangiogenesis is stimulated. However, the mechanism by which VEGFR1 is involved in lymphangiogenesis remains unclear. METHODS AND
RESULTS: To examine how important the tyrosine kinase (TK) of VEGFR1 is in lymphangiogenesis in K14 Vegf-A Tg mice, we crossed the K14 Vegf-A Tg mice with VEGFR1-TK-deficient mice to generate double mutant K14 Vegf-A Tg Vegfr1 tk(-/-) mice. K14 Vegf-A Tg Vegfr1 tk(-/-) mice exhibit a remarkable decrease in lymphangiogensis as well as angiogenesis in subcutaneous tissues. To address the mechanism underlying the decrease in lymphangiogensis, we investigated the recruitment of monocyte-macrophage-lineage cells into the skin. The recruitment of VEGFR1-expressing macrophages driven by VEGF-A was reduced in K14 Vegf-A Tg Vegfr1 tk(-/-) mice. Vegf-A Tg mice that received VEGFR1-TK-deficient bone marrow showed a reduction of macrophage recruitment, lymphangiogenesis and angiogenesis compared with those in K14 Vegf-A Tg mice.
CONCLUSIONS: VEGFR1 signaling promotes lymphangiogenesis as well as angiogenesis mainly by increasing bone marrow-derived macrophage recruitment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174461     DOI: 10.1161/ATVBAHA.107.150433

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  49 in total

Review 1.  Head and neck lymphatic tumors and bony abnormalities: a clinical and molecular review.

Authors:  Karthik Balakrishnan; Mark Majesky; Jonathan A Perkins
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

Review 2.  Myeloid cells and lymphangiogenesis.

Authors:  Adrian Zumsteg; Gerhard Christofori
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 3.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 4.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

5.  Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.

Authors:  Randall J Smith; Tai Yi; Bita Nasiri; Christopher K Breuer; Stelios T Andreadis
Journal:  FASEB J       Date:  2019-01-10       Impact factor: 5.191

6.  Changes in copper metabolism in rat liver after adrenalectomy.

Authors:  Yu A Vasilenko; E Yu Ilyechova; E A Zatulovskiy; P S Babich; L V Puchkova
Journal:  Dokl Biol Sci       Date:  2012-09-04

7.  Notch signaling in developmental and tumor angiogenesis.

Authors:  Natalie M Kofler; Carrie J Shawber; Thaned Kangsamaksin; Hasina Outtz Reed; Josephine Galatioto; Jan Kitajewski
Journal:  Genes Cancer       Date:  2011-12

8.  Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.

Authors:  Andrey Anisimov; Annamari Alitalo; Petra Korpisalo; Jarkko Soronen; Seppo Kaijalainen; Veli-Matti Leppänen; Michael Jeltsch; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

9.  Lymph node dissection in primary intrahepatic malignant mesothelioma: case report and implications for diagnosis and therapy.

Authors:  Bettina M Buchholz; Ines Gütgemann; Hans-Peter Fischer; Marcus Gorschlüter; Andreas Türler; Jörg C Kalff; Andreas Hirner; Jens Standop
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.